MicroRNA-552 Accelerates the Progression of Gastric Cancer by Targeting FOXO1 and Regulating PI3K/AKT Pathway

Table 1

Relationship between miR-552 expression and their clinic-pathological characteristics in GC patients.

Characteristics	Cases	miR-552		-value
		High	Low
Age (years)				0.08
≥60	38	20	18
<60	46	30	16
Gender				0.15
Male	58	32	26
Female	26	18	8
Tumor size (mm)				0.21
≤5.0	31	19	12
>5.0	53	31	22
Differentiation				0.009
Well/moderate	24	18	6
Poor	60	32	28
Lymph node metastasis				0.04
Yes	62	42	20
No	22	8	14
TNM stage				0.02
I-II	28	18	10
III-IV	56	32	24

Statistical analyses were performed by the χ² test. was considered significant.